Company Search:
Advanced Search
Sponsored Links
Sanofi S.A. - ADR Company Snapshot
Sanofi S.A. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other companies in this sector in the United States: Merck & Co. , Inc. (2016 sales of $39.81 billion of which 88% was Merck Pharmaceutical), GlaxoSmithKline plc ($37.50 billion of which 58% was Pharmaceuticals), and Novartis AG ($49.39 billion of which 66% was Innovative Medicines).

Sales Analysis. During the year ended December of 2016, sales at Sanofi S.A. were $38.31 billion. This is a decrease of 0.4% versus 2015, when the company's sales were $38.45 billion. Contributing to the drop in overall sales was the 3.4% decline in Vaccines, from $5.23 billion to $5.05 billion. There were also decreases in sales in Pharmaceuticals (down 1.8% to $32.28 billion) .
  Stock Performance Chart for Sanofi S.A. - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 44.60
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks 3.8%  
4 Weeks -9.9%   52 Weeks 10.5%  
Sanofi S.A. - ADR Key Data:
  Ticker: SNY Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 38,308,260,840
(Year Ending Jan 2017).
Employees: 106,859
  Currency: U.S. Dollars Market Cap: 112,013,259,119
  Fiscal Yr Ends: December Shares Outstanding: 2,511,508,052
  Share Type: Actions Ordinaires Closely Held Shares: 273,298,108
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.